Decibel hires Holtzman as CEO

Hearing loss company Decibel Therapeutics Inc. (Cambridge, Mass.) named Steven Holtzman CEO. In March, Holtzman retired as EVP of corporate development at Biogen Inc. (NASDAQ:BIIB). He is the founder and former chairman and CEO of Infinity Pharmaceuticals Inc. (NASDAQ:INFI) and before that was CBO at Millennium Pharmaceuticals Inc., which Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) acquired.

Third Rock Ventures' Kevin Starr, who had been Decibel's interim CEO, will remain its chairman. Third Rock led Decibel's $52 million series A round in October 2015. ...